Pfizer/Valneva Aim for FDA Approval of mRNA Shot for Lyme Disease

On Mar. 23, 2026, Pfizer, Inc. of New York City, NY and Valneva SE of Saint-Herblain, France announced that they would seek regulatory approval from the U.S. Food and Drug Administration (FDA) for an experimental mRNA (messenger ribonucleic acid) biologic shot against Lyme disease that they have jointly been developing since 2020. The shot, designated […]
Pfizer, BioNTech End mRNA COVID-19 Biologic Trial Early

After failing to recruit enough eligible volunteers to generate enough data in the U.S. to meet U.S. Food and Drug Administration (FDA) post-marketing evidence requirements, Pfizer, Inc. and BioNTech SE have halted a large clinical trial of their updated mRNA COVID-19 biologic. The study targeted healthy adults 50 to 64 years of age but fell […]
The Agonising Pain of COVID Vaccination Injury Victims

Sandra Byron had serious medical complications from a COVID vaccine in 2021. My hands have been rated as functionally useless. Can’t be touched. Can’t have a hot shower. Can’t have a normal meal. My brain doesn’t work properly. My speech comes and goes. She put in a claim through a vaccine compensation scheme. That was […]
Poland, Romania Resist Brussels Court Order to Pay $2.2 Billion to Pfizer

A court in Belgium has ordered Poland and Romania to proceed with paying €1.9 billion ($2.2 billion) for purchasing mRNA COVID-19 shots from Pfizer, Inc. and BioNTech SE in a case brought by Pfizer three years ago. The lawsuit and court judgement has intensified a broader legal dispute over mRNA COVID shot contracts signed by […]
Tech Company Agrees to $15 Million Settlement in COVID-19 Shot Bias Claim

An unidentified technology company has agreed to pay $15 million to resolve a federal investigation into alleged discrimination tied to COVID-19 shot exemption requests, according to the U.S. Equal Employment Opportunity Commission (EEOC). The matter was investigated by the EEOC’s Phoenix District Office and focused on the company’s handling of employee requests for religious accommodation during […]
National Cancer Institute to Study Ivermectin as Potential Cancer Treatment

The National Cancer Institute (NCI) plans to conduct a study on the use of ivermectin to treat cancer, according to a top official. Ivermectin is an FDA-approved anti-parasitic medication commonly used to treat various infections caused by internal and external parasites, such as parasitic worms and head lice, though the drug rose in popularity—and scrutiny—during […]
